Latest Articles
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study - FirstWord Pharma
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study FirstWord Pharma
Published: July 30, 2026, 9:59 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks
Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com
Published: July 30, 2026, 9:16 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - Karyopharm
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer Karyopharm
Published: July 30, 2026, 8:09 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - marketscreener.com
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer marketscreener.com
Published: July 30, 2026, 8:07 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - PR Newswire
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer PR Newswire
Published: July 30, 2026, 8:05 p.m.
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - markets.businessinsider.com
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps markets.businessinsider.com
Published: July 30, 2026, 3:58 p.m.
Contaminated drinking water is associated with increased risk of uterine cancer - 2 Minute Medicine
Contaminated drinking water is associated with increased risk of uterine cancer 2 Minute Medicine
Published: July 30, 2026, 3:19 p.m.
Alterations in Cellular Immunity in Patients With Endometriosis: Systematic Review and Meta-Analysis.
Determining the pathogenesis of endometriosis remains a major challenge in contemporary gynecology, and the investigation of alterations in cellular immunity may provide important insights into this issue. A comprehensive search …
Published: July 30, 2026, midnight
Nanomaterial Platforms for Endometriosis: A Systematic Review.
Endometriosis (EM) is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age worldwide, causing debilitating pelvic pain, infertility, and substantially impaired quality of life. Conventional hormonal …
Published: July 30, 2026, midnight
Link copied to clipboard!